US Pharma Marketing
HomeEditorial DeskAboutContact
Manufacturing

Develop site-centric protocols to optimize enrollment and maximize performance - Pharmaceutical Technology

In an attempt to meet regulatory expectations, clinical trials are challenged by highly complex protocol design. But these study plans… Credit: via Shutterstock. In an attempt to meet regulatory expectations, clinical trials are challenged by highly complex protocol design. But these study plans can fail to reflect the standard of care, site capabilities, or the realities of patient eligibility. The result is often slower site activation, greater burden on patients and staff, limited access and enrollment, increased likelihood of costly amendments, and in some cases, study failure. You will receive an email shortly. Please check your inbox to download the…

Alexander Love · 2026-09-07

Source: Pharmaceutical Technology

US Pharma MarketingPrivacy PolicyEditorial PolicyContact